These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

446 related items for PubMed ID: 15748094

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. COPD exacerbation frequency, pharmacotherapy and resource use: an observational study in UK primary care.
    Thomas M, Radwan A, Stonham C, Marshall S.
    COPD; 2014 Jun; 11(3):300-9. PubMed ID: 24152210
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Effects of inhaled corticosteroids on mortality and hospitalisation in elderly asthma and chronic obstructive pulmonary disease patients: appraising the evidence.
    Schmier JK, Halpern MT, Jones ML.
    Drugs Aging; 2005 Jun; 22(9):717-29. PubMed ID: 16156676
    [Abstract] [Full Text] [Related]

  • 25. Medications for COPD: a review of effectiveness.
    Grimes GC, Manning JL, Patel P, Via RM.
    Am Fam Physician; 2007 Oct 15; 76(8):1141-8. PubMed ID: 17990836
    [Abstract] [Full Text] [Related]

  • 26. [Clinical efficacy of inhaled corticosteroids in COPD].
    Kamoi H, Yoshikawa T, Hirata K.
    Nihon Rinsho; 2007 Apr 15; 65(4):696-701. PubMed ID: 17419390
    [Abstract] [Full Text] [Related]

  • 27. Common lung conditions: chronic obstructive pulmonary disease.
    Delzell JE.
    FP Essent; 2013 Jun 15; 409():23-31. PubMed ID: 23767419
    [Abstract] [Full Text] [Related]

  • 28. Benefits and risks of inhaled corticosteroids in chronic obstructive pulmonary disease.
    Bonay M, Bancal C, Crestani B.
    Drug Saf; 2002 Jun 15; 25(1):57-71. PubMed ID: 11820912
    [Abstract] [Full Text] [Related]

  • 29. Inhaled corticosteroids in COPD: a controversy.
    Barnes PJ.
    Respiration; 2010 Jun 15; 80(2):89-95. PubMed ID: 20501985
    [Abstract] [Full Text] [Related]

  • 30. Pharmacotherapy for mortality reduction in chronic obstructive pulmonary disease.
    Sin DD, Man SF.
    Proc Am Thorac Soc; 2006 Sep 15; 3(7):624-9. PubMed ID: 16963545
    [Abstract] [Full Text] [Related]

  • 31. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease.
    Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, Yates JC, Vestbo J, TORCH investigators.
    N Engl J Med; 2007 Feb 22; 356(8):775-89. PubMed ID: 17314337
    [Abstract] [Full Text] [Related]

  • 32. Similarities and differences in asthma and chronic obstructive pulmonary disease exacerbations.
    Pauwels RA.
    Proc Am Thorac Soc; 2004 Feb 22; 1(2):73-6. PubMed ID: 16113416
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Friend or foe: combination therapy with inhaled corticosteroids and long-acting beta2-agonists in chronic obstructive pulmonary disease (COPD)].
    Gillissen A, Gessner C, Hoheisel G, Juergens U.
    Pneumologie; 2008 Jul 22; 62(7):430-7. PubMed ID: 18398787
    [Abstract] [Full Text] [Related]

  • 35. Development of an economic model to assess the cost effectiveness of treatment interventions for chronic obstructive pulmonary disease.
    Spencer M, Briggs AH, Grossman RF, Rance L.
    Pharmacoeconomics; 2005 Jul 22; 23(6):619-37. PubMed ID: 15960557
    [Abstract] [Full Text] [Related]

  • 36. A benefit-risk assessment of inhaled long-acting beta2-agonists in the management of obstructive pulmonary disease.
    Sovani MP, Whale CI, Tattersfield AE.
    Drug Saf; 2004 Jul 22; 27(10):689-715. PubMed ID: 15350154
    [Abstract] [Full Text] [Related]

  • 37. Tolerability profiles of leukotriene receptor antagonists and long-acting beta2-adrenoceptor agonists in combination with inhaled corticosteroids for treatment of asthma: a review.
    Colucci R, Fornai M, Tuccori M, Antonioli L, Pasqualetti G, Blandizzi C, Del Tacca M.
    J Asthma; 2007 Jul 22; 44(6):411-22. PubMed ID: 17654125
    [Abstract] [Full Text] [Related]

  • 38. Do chronic inhaled steroids alone or in combination with a bronchodilator prolong life in chronic obstructive pulmonary disease patients?
    Sin DD, Man SF.
    Curr Opin Pulm Med; 2007 Mar 22; 13(2):90-7. PubMed ID: 17255798
    [Abstract] [Full Text] [Related]

  • 39. Inhaled corticosteroids in the long-term management of patients with chronic obstructive pulmonary disease.
    Sin DD, Man SF.
    Drugs Aging; 2003 Mar 22; 20(12):867-80. PubMed ID: 14565780
    [Abstract] [Full Text] [Related]

  • 40. The burden of chronic obstructive pulmonary disease associated with maintenance monotherapy in the UK.
    Edwards SC, Fairbrother SE, Scowcroft A, Chiu G, Ternouth A, Lipworth BJ.
    Int J Chron Obstruct Pulmon Dis; 2016 Mar 22; 11():2851-2858. PubMed ID: 27920512
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.